Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04902326
Other study ID # HUM00188543
Secondary ID 1R18DK122418-01
Status Completed
Phase N/A
First received
Last updated
Start date September 16, 2021
Est. completion date September 18, 2023

Study information

Verified date October 2023
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with prediabetes can significantly reduce their risk of developing type 2 diabetes mellitus (T2DM) by participating in a Diabetes Prevention Program (DPP) or using metformin, but very few patients with prediabetes engage in these strategies. This randomized controlled trial will compare, among adults with prediabetes, the effectiveness of financial incentives, tailored messages based on self-determination theory (SDT) principles, and the combination of financial incentives plus tailored messages based on SDT principles in decreasing hemoglobin A1c (HbA1c) and weight and in increasing participation in a DPP or use of metformin. Our main hypotheses are that the mean decrease in HbA1c will be greater in the arm that receives a combination of financial incentives plus tailored messages than in the arm that receives generic health education messages, and that the mean decrease in HbA1c will be greater in the arm that receives a combination of financial incentives plus tailored messages than in the arm that receives financial incentives alone and the arm that receives tailored messages alone. The study will also identify moderators and mediators of the effectiveness of the interventions and evaluate facilitators of and barriers to scalability, acceptability, and sustainability of the different interventions.


Recruitment information / eligibility

Status Completed
Enrollment 380
Est. completion date September 18, 2023
Est. primary completion date September 18, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Primary Care Provider part of Michigan Medicine - Body mass index (BMI) of 25 or higher (23 or higher if of Asian descent) - Primary health insurance is U-M Premier Care - Recent Hgb (hemoglobin) A1c 5.7 - 6.4% (inclusive) Exclusion Criteria: - Participated in pretesting of intervention materials - Diagnosis of type 2 Diabetes Mellitus - Serious mental health conditions (described by protocol) - End stage renal disease (described by protocol) - Alcohol dependence and opioid dependence (described by protocol) - Unable to send and receive several text messages weekly - No regular access to a smart phone or tablet with data capabilities or Wireless Fidelity (WiFi) connection at home - Currently taking metformin - Unable to take metformin due to contraindications or side effects - Participated in a Diabetes Prevention Program covered by University of Michigan Premier Care insurance - Currently enrolled in an interventional research study that is examining how a diet, program, or drug might: promote physical exercise, healthy eating habits, or weight loss; lower blood pressure; or lower blood sugar - Not planning to live in local area over the next year - Pregnant or planning a pregnancy in the next year - Received treatment for an eating disorder (e.g. anorexia or bulimia), not including binge-eating disorder, in last 12 months - Intensive cancer treatment such as bone marrow transplant, chemotherapy, radiation, or cancer related surgery (not including hormonal chemotherapy like Tamoxifen) in last six months or near future - Organ transplant in last six months - Bariatric/ gastric bypass surgery, gastric sleeve surgery, or gastric balloon procedure in last six months - Stroke, heart attack, heart surgery, or hospitalization for congestive heart failure in the past three months - Other serious health issues or personal concerns that could prevent participant from completing study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Automated educational text messages
During the first two weeks, participants receive a series of educational messages delivered via text message. These messages welcome participants to the study, set expectations for the next 12 months, and establish a general level of knowledge among all participants on prediabetes, the Diabetes Prevention Program (DPP), and metformin. For the next 11.5 months, participants receive three automated text messages per week that provide evidence-based educational content about prediabetes and tips on prevention. Additionally, participants receive monthly messages reminding them about their health insurance plan's coverage of the DPP at no cost and coverage of metformin as a low co-pay medication, and monthly messages providing feedback on their participation in the DPP and use of metformin in the previous calendar month. Participants' PCPs receive quarterly chart updates about participation in the DPP and use of metformin, and A1c results at enrollment and 6 and 12 months.
Autonomy-supportive automated educational text messages
Participants receive the same text messages as in the automated educational text message intervention, but the thrice weekly messages have been modified, where applicable, to support the participant's autonomy, in accordance with principles of Self-Determination Theory. Participants' PCPs receive quarterly chart updates about participation in the DPP and use of metformin, and A1c results at enrollment and 6 and 12 months.
Financial incentives
Participants in this arm have the opportunity to earn a financial incentive ranging from $50 to $250 per month for taking an evidence-based action to prevent T2DM (i.e., engagement in a DPP or fill of a metformin prescription) in the previous month.
Tailored text messages
Participants receive twice-weekly tailored text messages that link evidence-based actions to prevent T2DM to the participant's self-identified top values, roles, and strengths. Text messages are also tailored, when possible, to participants' self-reported importance of taking action to try to prevent T2DM (i.e., participating in the DPP or taking metformin), confidence in being able to take such preventive action, and past preventive actions taken.

Locations

Country Name City State
United States University of Michigan Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in hemoglobin A1C from baseline to 6 months Hemoglobin A1C will be tested at clinical lab using blood sample from venipuncture. baseline and 6 months
Primary Change in hemoglobin A1C from baseline to 12 months Hemoglobin A1C will be tested at clinical lab using blood sample from venipuncture. baseline and12 months
Secondary Change in weight from baseline to 6 months Participants will measure their body weight using a scale in their home. baseline and 6 months
Secondary Change in weight from baseline to 12 months Participants will measure their body weight using a scale in their home. baseline and 12 months
Secondary Engagement in DPP Health insurance claims will be used to collect this data. up to 12 months
Secondary Proportion of days covered by Metformin Prescription plan claims will be used to collect this data. up to 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05052918 - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes N/A
Completed NCT03714646 - Beta Glucan and Acetate Production N/A
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT03480022 - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS Phase 3
Active, not recruiting NCT05290233 - Time Restricted Eating Plus Exercise for Weight Management N/A
Withdrawn NCT05726409 - Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes N/A
Completed NCT02834078 - Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome N/A
Recruiting NCT04168372 - Fructose: Substrate, Stimulus, or Both? N/A
Completed NCT03272074 - Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes N/A
Not yet recruiting NCT05939349 - A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes N/A
Completed NCT04978376 - TRE With Physical Activity for Weight Management N/A
Recruiting NCT03997656 - A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia N/A
Recruiting NCT05166785 - BRInging the Diabetes Prevention Program to GEriatric Populations N/A
Completed NCT01729078 - Dietary Interventions in Prediabetes N/A
Completed NCT04507685 - Asian Indian Prediabetes Study N/A
Completed NCT03292315 - Once Weekly GLP-1 in Persons With Spinal Cord Injury Phase 4
Active, not recruiting NCT05353790 - Dietary Exchanges With Avocado and Mango in Pre-diabetes N/A
Active, not recruiting NCT03804892 - Can Brisk Walking Combined With Ingestion of a Lipid-lowering Drug Improve Fat Metabolism in Muscle? N/A